Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies

Authors: Ling Li, Chen Yang, Yuliang Zhao, Xiaoxi Zeng, Fang Liu, Ping Fu

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Hyperuricemia has been reported to be associated with chronic kidney disease (CKD). However whether an elevated serum uric acid level is an independent risk factor for new-onset CKD remained controversial.

Methods

A systematic review and meta-analysis using a literature search of online databases including PubMed, Embase, Ovid and ISI Web/Web of Science was conducted. Summary adjusted odds ratios with corresponding 95% confidence intervals (95% CI) were calculated to evaluate the risk estimates of hyperuricemia for new-onset CKD.

Results

Thirteen studies containing 190,718 participants were included. A significant positive association was found between elevated serum uric acid levels and new-onset CKD at follow-up (summary OR, 1.15; 95% CI, 1.05–1.25). Hyperuricemia was found be an independent predictor for the development of newly diagnosed CKD in non-CKD patients (summary OR, 2.35; 95% CI, 1.59–3.46). This association increased with increasing length of follow-up. No significant differences were found for risk estimates of the associations between elevated serum uric acid levels and developing CKD between males and females.

Conclusions

With long-term follow-up of non-CKD individuals, elevated serum uric acid levels showed an increased risk for the development of chronic renal dysfunction.
Appendix
Available only for authorised users
Literature
1.
go back to reference Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G: Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from kidney disease improving global outcomes. Kidney Int. 2007, 72: 247-259.CrossRefPubMed Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G: Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from kidney disease improving global outcomes. Kidney Int. 2007, 72: 247-259.CrossRefPubMed
2.
go back to reference Tanner RM, Brown TM, Muntner P: Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease. Curr Hypertens Rep. 2012, 14: 152-159.CrossRefPubMed Tanner RM, Brown TM, Muntner P: Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease. Curr Hypertens Rep. 2012, 14: 152-159.CrossRefPubMed
3.
go back to reference Pyram R, Kansara A, Banerji MA, Loney-Hutchinson L: Chronic kidney disease and diabetes. Maturitas. 2012, 71: 94-103.CrossRefPubMed Pyram R, Kansara A, Banerji MA, Loney-Hutchinson L: Chronic kidney disease and diabetes. Maturitas. 2012, 71: 94-103.CrossRefPubMed
4.
go back to reference Levin A: Identification of patients and risk factors in chronic kidney disease–evaluating risk factors and therapeutic strategies. Nephrol Dial Transplant. 2001, 16 (Suppl 7): 57-60.CrossRefPubMed Levin A: Identification of patients and risk factors in chronic kidney disease–evaluating risk factors and therapeutic strategies. Nephrol Dial Transplant. 2001, 16 (Suppl 7): 57-60.CrossRefPubMed
5.
go back to reference Becker MA, Jolly M: Hyperuricemia and associated diseases. Rheum Dis Clin North Am. 2006, 32: 275-293. v-viCrossRefPubMed Becker MA, Jolly M: Hyperuricemia and associated diseases. Rheum Dis Clin North Am. 2006, 32: 275-293. v-viCrossRefPubMed
6.
go back to reference Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, Feng L, Nakagawa T, Watanabe S, Hosoyamada M, Endou H, Lipkowitz M, Abramson R, Mu W, Johnson RJ: Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol. 2005, 25: 425-433.CrossRefPubMed Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, Feng L, Nakagawa T, Watanabe S, Hosoyamada M, Endou H, Lipkowitz M, Abramson R, Mu W, Johnson RJ: Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol. 2005, 25: 425-433.CrossRefPubMed
7.
go back to reference Reungjui S, Roncal CA, Mu W, Srinivas TR, Sirivongs D, Johnson RJ, Nakagawa T: Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol. 2007, 18: 2724-2731.CrossRefPubMed Reungjui S, Roncal CA, Mu W, Srinivas TR, Sirivongs D, Johnson RJ, Nakagawa T: Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol. 2007, 18: 2724-2731.CrossRefPubMed
8.
go back to reference Kang DH, Park SK, Lee IK, Johnson RJ: Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005, 16: 3553-3562.CrossRefPubMed Kang DH, Park SK, Lee IK, Johnson RJ: Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005, 16: 3553-3562.CrossRefPubMed
9.
go back to reference Ford ES, Li C, Cook S, Choi HK: Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007, 115: 2526-2532.CrossRefPubMed Ford ES, Li C, Cook S, Choi HK: Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007, 115: 2526-2532.CrossRefPubMed
10.
go back to reference Kang DH, Chen W: Uric acid and chronic kidney disease: new understanding of an old problem. Semin Nephrol. 2011, 31: 447-452.CrossRefPubMed Kang DH, Chen W: Uric acid and chronic kidney disease: new understanding of an old problem. Semin Nephrol. 2011, 31: 447-452.CrossRefPubMed
11.
go back to reference Jalal DI, Chonchol M, Chen W, Targher G: Uric acid as a target of therapy in CKD. Am J Kidney Dis. 2013, 61: 134-146.CrossRefPubMed Jalal DI, Chonchol M, Chen W, Targher G: Uric acid as a target of therapy in CKD. Am J Kidney Dis. 2013, 61: 134-146.CrossRefPubMed
15.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283: 2008-2012.CrossRefPubMed Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283: 2008-2012.CrossRefPubMed
16.
go back to reference Ryoo JH, Choi JM, Oh CM, Kim MG: The association between uric acid and chronic kidney disease in Korean men: a 4-year follow-up study. J Korean Med Sci. 2013, 28: 855-860.CrossRefPubMedPubMedCentral Ryoo JH, Choi JM, Oh CM, Kim MG: The association between uric acid and chronic kidney disease in Korean men: a 4-year follow-up study. J Korean Med Sci. 2013, 28: 855-860.CrossRefPubMedPubMedCentral
17.
go back to reference Chang HY, Lee PH, Lei CC, Tung CW, Hsu YC, Huang TJ, Lu LC, Lin CL: Hyperuricemia is an independent risk factor for new onset micro-albuminuria in a middle-aged and elderly population: a prospective cohort study in taiwan. PLoS One. 2013, 8: e61450-CrossRefPubMedPubMedCentral Chang HY, Lee PH, Lei CC, Tung CW, Hsu YC, Huang TJ, Lu LC, Lin CL: Hyperuricemia is an independent risk factor for new onset micro-albuminuria in a middle-aged and elderly population: a prospective cohort study in taiwan. PLoS One. 2013, 8: e61450-CrossRefPubMedPubMedCentral
18.
go back to reference Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, Negri C, Bonora E: Serum uric Acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care. 2012, 35: 99-104.CrossRefPubMed Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, Negri C, Bonora E: Serum uric Acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care. 2012, 35: 99-104.CrossRefPubMed
19.
go back to reference Sonoda H, Takase H, Dohi Y, Kimura G: Uric acid levels predict future development of chronic kidney disease. Am J Nephrol. 2011, 33: 352-357.CrossRefPubMed Sonoda H, Takase H, Dohi Y, Kimura G: Uric acid levels predict future development of chronic kidney disease. Am J Nephrol. 2011, 33: 352-357.CrossRefPubMed
20.
go back to reference Kawashima M, Wada K, Ohta H, Terawaki H, Aizawa Y: Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study. BMC Nephrol. 2011, 12: 31-CrossRefPubMedPubMedCentral Kawashima M, Wada K, Ohta H, Terawaki H, Aizawa Y: Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study. BMC Nephrol. 2011, 12: 31-CrossRefPubMedPubMedCentral
21.
go back to reference Mok Y, Lee SJ, Kim MS, Cui W, Moon YM, Jee SH: Serum uric acid and chronic kidney disease: the Severance cohort study. Nephrol Dial Transplant. 2012, 27: 1831-1835.CrossRefPubMed Mok Y, Lee SJ, Kim MS, Cui W, Moon YM, Jee SH: Serum uric acid and chronic kidney disease: the Severance cohort study. Nephrol Dial Transplant. 2012, 27: 1831-1835.CrossRefPubMed
22.
go back to reference Yamada T, Fukatsu M, Suzuki S, Wada T, Joh T: Elevated serum uric acid predicts chronic kidney disease. Am J Med Sci. 2011, 342: 461-466.CrossRefPubMed Yamada T, Fukatsu M, Suzuki S, Wada T, Joh T: Elevated serum uric acid predicts chronic kidney disease. Am J Med Sci. 2011, 342: 461-466.CrossRefPubMed
23.
go back to reference Wang S, Shu Z, Tao Q, Yu C, Zhan S, Li L: Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan. Nephrology (Carlton). 2011, 16: 767-776.CrossRef Wang S, Shu Z, Tao Q, Yu C, Zhan S, Li L: Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan. Nephrology (Carlton). 2011, 16: 767-776.CrossRef
24.
go back to reference Jalal DI, Rivard CJ, Johnson RJ, Maahs DM, McFann K, Rewers M, Snell-Bergeon JK: Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant. 2010, 25: 1865-1869.CrossRefPubMedPubMedCentral Jalal DI, Rivard CJ, Johnson RJ, Maahs DM, McFann K, Rewers M, Snell-Bergeon JK: Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant. 2010, 25: 1865-1869.CrossRefPubMedPubMedCentral
25.
go back to reference Yen CJ, Chiang CK, Ho LC, Hsu SH, Hung KY, Wu KD, Tsai TJ: Hyperuricemia associated with rapid renal function decline in elderly Taiwanese subjects. J Formos Med Assoc. 2009, 108: 921-928.CrossRefPubMed Yen CJ, Chiang CK, Ho LC, Hsu SH, Hung KY, Wu KD, Tsai TJ: Hyperuricemia associated with rapid renal function decline in elderly Taiwanese subjects. J Formos Med Assoc. 2009, 108: 921-928.CrossRefPubMed
26.
go back to reference Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS: Uric acid and incident kidney disease in the community. J Am Soc Nephrol. 2008, 19: 1204-1211.CrossRefPubMedPubMedCentral Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS: Uric acid and incident kidney disease in the community. J Am Soc Nephrol. 2008, 19: 1204-1211.CrossRefPubMedPubMedCentral
27.
go back to reference Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, Ponholzer A, Madersbacher S, Oberbauer R, Klauser-Braun R: Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant. 2008, 23: 1265-1273.CrossRefPubMed Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, Ponholzer A, Madersbacher S, Oberbauer R, Klauser-Braun R: Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant. 2008, 23: 1265-1273.CrossRefPubMed
28.
go back to reference Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, Lolekha P, Cheepudomwit S, Yipintsoi T: Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005, 16: 791-799.CrossRefPubMed Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, Lolekha P, Cheepudomwit S, Yipintsoi T: Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005, 16: 791-799.CrossRefPubMed
29.
go back to reference Li YL, Wang L, Li J, Huang Y, Yuan WM: The correlation between uric acid and the incidence and prognosis of kidney diseases: a systematic review and meta-analysis of cohort studies. Zhonghua Nei Ke Za Zhi. 2011, 50: 555-561.PubMed Li YL, Wang L, Li J, Huang Y, Yuan WM: The correlation between uric acid and the incidence and prognosis of kidney diseases: a systematic review and meta-analysis of cohort studies. Zhonghua Nei Ke Za Zhi. 2011, 50: 555-561.PubMed
30.
go back to reference Chen LK, Lin MH, Lai HY, Hwang SJ, Chiou ST: Uric acid: a surrogate of insulin resistance in older women. Maturitas. 2008, 59: 55-61.CrossRefPubMed Chen LK, Lin MH, Lai HY, Hwang SJ, Chiou ST: Uric acid: a surrogate of insulin resistance in older women. Maturitas. 2008, 59: 55-61.CrossRefPubMed
31.
go back to reference Xue C, Ye XD, Li W, Peng Q, Ding HY, Zhang YH, He DF, Bai X, Huang Y, Song YS, Pang L, Liao YH: Prevalence of chronic kidney disease in Jing adults in China: a village-based study. Clin Nephrol. 2013, 79: 50-56.CrossRefPubMed Xue C, Ye XD, Li W, Peng Q, Ding HY, Zhang YH, He DF, Bai X, Huang Y, Song YS, Pang L, Liao YH: Prevalence of chronic kidney disease in Jing adults in China: a village-based study. Clin Nephrol. 2013, 79: 50-56.CrossRefPubMed
32.
go back to reference Feig DI, Soletsky B, Johnson RJ: Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008, 300: 924-932.CrossRefPubMedPubMedCentral Feig DI, Soletsky B, Johnson RJ: Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008, 300: 924-932.CrossRefPubMedPubMedCentral
33.
go back to reference Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A: Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol. 2007, 39: 1227-1233.CrossRefPubMed Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A: Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol. 2007, 39: 1227-1233.CrossRefPubMed
34.
go back to reference Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, de Zoysa JR, Fassett RG, Faull R, Harris DC, Hawley CM, Kanellis J, Palmer SC, Perkovic V, Pascoe EM, Rangan GK, Walker RJ, Walters G, Johnson DW: Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant. 2014, 29: 406-413.CrossRefPubMed Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, de Zoysa JR, Fassett RG, Faull R, Harris DC, Hawley CM, Kanellis J, Palmer SC, Perkovic V, Pascoe EM, Rangan GK, Walker RJ, Walters G, Johnson DW: Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant. 2014, 29: 406-413.CrossRefPubMed
35.
go back to reference Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD: Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011, 6: 2364-2373.CrossRefPubMedPubMedCentral Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD: Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011, 6: 2364-2373.CrossRefPubMedPubMedCentral
36.
go back to reference Palmer TM, Nordestgaard BG, Benn M, Tybjærg-Hansen A, Davey Smith G, Lawlor DA, Timpson NJ: Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ. 2013, 347: f4262-CrossRefPubMedPubMedCentral Palmer TM, Nordestgaard BG, Benn M, Tybjærg-Hansen A, Davey Smith G, Lawlor DA, Timpson NJ: Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ. 2013, 347: f4262-CrossRefPubMedPubMedCentral
37.
go back to reference Spencer HW, Yarger WE, Robinson RR: Alterations of renal function during dietary-induced hyperuricemia in the rat. Kidney Int. 1976, 9: 489-500.CrossRefPubMed Spencer HW, Yarger WE, Robinson RR: Alterations of renal function during dietary-induced hyperuricemia in the rat. Kidney Int. 1976, 9: 489-500.CrossRefPubMed
38.
go back to reference Umekawa T, Chegini N, Khan SR: Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant. 2003, 18: 664-669.CrossRefPubMed Umekawa T, Chegini N, Khan SR: Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant. 2003, 18: 664-669.CrossRefPubMed
39.
go back to reference Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ: Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002, 282: F991-F997.CrossRefPubMed Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ: Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002, 282: F991-F997.CrossRefPubMed
40.
go back to reference Han HJ, Lim MJ, Lee YJ, Lee JH, Yang IS, Taub M: Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappaB. Am J Physiol Renal Physiol. 2007, 292: F373-F381.CrossRefPubMed Han HJ, Lim MJ, Lee YJ, Lee JH, Yang IS, Taub M: Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappaB. Am J Physiol Renal Physiol. 2007, 292: F373-F381.CrossRefPubMed
41.
go back to reference Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ: A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002, 13: 2888-2897.CrossRefPubMed Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ: A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002, 13: 2888-2897.CrossRefPubMed
42.
go back to reference Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS, Jo I, Johnson RJ, Kang DH: Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Renal Physiol. 2013, 304: F471-F480.CrossRefPubMed Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS, Jo I, Johnson RJ, Kang DH: Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Renal Physiol. 2013, 304: F471-F480.CrossRefPubMed
Metadata
Title
Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies
Authors
Ling Li
Chen Yang
Yuliang Zhao
Xiaoxi Zeng
Fang Liu
Ping Fu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-122

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue